VehicleMay 30, 2023
Model Y steering wheel/handle bar recall — NHTSA campaign 23V385000
Tesla, Inc. (Tesla) is recalling certain 2022-2023 Model Y vehicles. The steering wheel fastener may be loose.
steering wheel/handle barTesla, Inc.
Latest records
Latest recalls — page 312
The newest recall records with useful source details are listed here.
VehicleMay 26, 2023
Ford labels recall — NHTSA campaign 23V379000
Ford Motor Company (Ford) is recalling certain 2022-2023 Bronco, 2023 Super Duty F-250, and 2019-2023 Ranger vehicles. The Tire and Loading Information (TREAD) label states the incorrect…
labelsFord Motor Company
VehicleMay 26, 2023
Ford engine recall — NHTSA campaign 23V380000
Ford Motor Company (Ford) is recalling certain 2020-2023 Escape, 2022-2023 Maverick, and 2021-2023 Corsair vehicles equipped with 2.5L HEV or PHEV engines. In the event of an engine…
engineFord Motor Company
VehicleMay 25, 2023
Nissan Rogue critical fasteners recall — NHTSA campaign 23V374000
Nissan North America, Inc. (Nissan) is recalling certain 2023 Nissan Rogue vehicles. The fastener in the rear seat belt anchor attachment points may not have been tightened properly and can…
critical fastenersNissan North America, Inc.
DrugMay 24, 2023
Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01) recall — FDA D-0574-2023
Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C.
Class IIFDA: TerminatedHikma Pharmaceuticals USA Inc.
DrugMay 24, 2023
RemedyRepack LORazepam Injection, 2mg / mL Single Dose vial 1ml vial recall — FDA D-0576-2023
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or…
Class IIFDA: TerminatedRemedyRepack Inc.
DrugMay 24, 2023
RemedyRepack Pyrazinamide, 500 mg Tablet recall — FDA D-0578-2023
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or…
Class IIFDA: OngoingRemedyRepack Inc.
DrugMay 24, 2023
RemedyRepack Ketotifen Fumarate 0.025 %, Antihistamine eye drops, 5mL bottle, MFG: Akorn recall — FDA D-0577-2023
CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or…
Class IIFDA: OngoingRemedyRepack Inc.
DrugMay 24, 2023
Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection recall — FDA D-0579-2023
Subpotent: Low anti-factor IIa Potency.
Class IIFDA: TerminatedB. Braun Medical Inc.
VehicleMay 18, 2023
Bronco critical fasteners recall — NHTSA campaign 23V358000
Ford Motor Company (Ford) is recalling certain 2021-2023 Bronco vehicles built with the 5-Door body style. The first-row seat belt latch plates may be difficult to access from their stowed…
critical fastenersFord Motor Company
VehicleMay 18, 2023
Chrysler column recall — NHTSA campaign 23V352000
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Grand Cherokee and 2021-2023 Jeep Grand Cherokee L vehicles. An incorrectly assembled steering column intermediate shaft may…
columnChrysler (FCA US, LLC)
DrugMay 17, 2023
Calcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 recall — FDA D-0568-2023
Presence of Foreign Substance: Glass splinter particle entrapped inside the pump ball seat rendered the pump inoperable.
Class IIFDA: CompletedApotex Corp.
DrugMay 17, 2023
Atovaquone Oral Suspension USP, 750 mg/5 mL recall — FDA D-0567-2023
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
Class IFDA: OngoingCamber Pharmaceuticals Inc.
DrugMay 17, 2023
Gabapentin Tablets, USP 600 mg recall — FDA D-0570-2023
Product mixup: one foreign tablet found in product.
Class IIIFDA: TerminatedThe Harvard Drug Group
VehicleMay 12, 2023
Ford camera recall — NHTSA campaign 23V342000
Ford Motor Company (Ford) is recalling certain 2020-2023 Explorer, Lincoln Aviator, and 2020-2022 Lincoln Corsair vehicles equipped with a 360-degree camera. The video output may fail,…
cameraFord Motor Company
VehicleMay 11, 2023
General Motors vehicle latch anchor recall — NHTSA campaign 23V339000
General Motors, LLC (GM) is recalling certain 2020-2023 Chevrolet Equinox and GMC Terrain vehicles. The four rear-seat lower child seat LATCH anchorage bars may have excessive powder…
vehicle latch anchorGeneral Motors, LLC
VehicleMay 11, 2023
Chrysler labels recall — NHTSA campaign 23V336000
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Grand Cherokee L and Grand Cherokee vehicles. The air bag warning label may be missing from the dashboard. As such, these vehicles…
labelsChrysler (FCA US, LLC)
DrugMay 10, 2023
Family Dollar Stores, LLC Advil Liqui-Gels Solubilized Ibuprofen Capsules, 200 mg Pain recall — FDA D-0566-2023
CGMP deviation: product outside labeled storage temperature requirements.
Class IIFDA: OngoingFamily Dollar Stores, LLC.
DrugMay 10, 2023
Seatex Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-Sterile Solution Net recall — FDA D-0562-2023
Superpotent Drug and Failed Impurities/Degradation Products: formula does not adhere to the labeled specifications
Class IIFDA: OngoingSeatex LLC
DrugMay 10, 2023
Gadget Island NUX Male Enhancement capsule, 1-count blister card recall — FDA D-0572-2023
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of…
Class IFDA: OngoingGadget Island, Inc.
DrugMay 10, 2023
Family Dollar Stores, LLC Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer recall — FDA D-0563-2023
CGMP deviation: product outside labeled storage temperature requirements.
Class IIFDA: OngoingFamily Dollar Stores, LLC.
DrugMay 10, 2023
Lidocaine Patch 5%, 1 patch (63629-8755-20) recall — FDA D-0556-2023
Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive…
Class IIIFDA: OngoingBryant Ranch Prepack, Inc.
DrugMay 10, 2023
Gadget Island Pro Power Knight Plus capsule, 2550mg, 1-count blister card recall — FDA D-0571-2023
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of…
Class IFDA: OngoingGadget Island, Inc.
DrugMay 10, 2023
Gadget Island DYNAMITE SUPER capsule, 58,000 MG, 1-count blister card, Made in America, UPC recall — FDA D-0573-2023
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of…
Class IFDA: OngoingGadget Island, Inc.
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories